- Home
- MDAI vs PYPD Comparison
MDAI vs PYPD Comparison
Compare MDAI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- PYPD
- Stock Information
- Founded
- MDAI 2013
- PYPD 2008
- Country
- MDAI United States
- PYPD Israel
- Employees
- MDAI N/A
- PYPD N/A
- Industry
- MDAI Medical/Dental Instruments
- PYPD Medical/Dental Instruments
- Sector
- MDAI Health Care
- PYPD Health Care
- Exchange
- MDAI Nasdaq
- PYPD Nasdaq
- Market Cap
- MDAI 27.8M
- PYPD 30.1M
- IPO Year
- MDAI N/A
- PYPD 2020
- Fundamental
- Price
- MDAI $1.23
- PYPD $2.75
- Analyst Decision
- MDAI Strong Buy
- PYPD Strong Buy
- Analyst Count
- MDAI 2
- PYPD 2
- Target Price
- MDAI $4.75
- PYPD $10.50
- AVG Volume (30 Days)
- MDAI 421.8K
- PYPD 12.4K
- Earning Date
- MDAI 05-06-2025
- PYPD 05-07-2025
- Dividend Yield
- MDAI N/A
- PYPD N/A
- EPS Growth
- MDAI N/A
- PYPD N/A
- EPS
- MDAI N/A
- PYPD N/A
- Revenue
- MDAI $29,581,000.00
- PYPD N/A
- Revenue This Year
- MDAI N/A
- PYPD N/A
- Revenue Next Year
- MDAI $49.47
- PYPD N/A
- P/E Ratio
- MDAI N/A
- PYPD N/A
- Revenue Growth
- MDAI 63.83
- PYPD N/A
- 52 Week Low
- MDAI $0.82
- PYPD $2.37
- 52 Week High
- MDAI $3.25
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- MDAI 37.49
- PYPD 44.79
- Support Level
- MDAI $1.04
- PYPD $2.66
- Resistance Level
- MDAI $1.31
- PYPD $2.75
- Average True Range (ATR)
- MDAI 0.15
- PYPD 0.12
- MACD
- MDAI -0.01
- PYPD -0.01
- Stochastic Oscillator
- MDAI 24.05
- PYPD 31.97
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.